Remnant cholesterol, iron status and diabetes mellitus: a dose-response relationship and mediation analysis
- PMID: 38475846
- PMCID: PMC10929145
- DOI: 10.1186/s13098-024-01304-0
Remnant cholesterol, iron status and diabetes mellitus: a dose-response relationship and mediation analysis
Abstract
Background: Remnant cholesterol (RC) is recognized as a risk factor for diabetes mellitus (DM). Although iron status has been shown to be associated with cholesterol metabolism and DM, the association between RC, iron status, and DM remains unclear. We examined the relationship between RC and iron status and investigated the role of iron status in the association between RC and DM.
Methods: A total of 7308 patients were enrolled from the China Health and Nutrition Survey. RC was calculated as total cholesterol minus low-density lipoprotein cholesterol and high-density lipoprotein cholesterol. Iron status was assessed as serum ferritin (SF) and total body iron (TBI). DM was ascertained by self-reported physician diagnosis and/or antidiabetic drug use and/or fasting plasma glucose ≥ 126 mg/dL and/or glycated haemoglobin ≥ 6.5%. General linear models were used to evaluate the relationships between RC and iron status. Restricted cubic splines were used to assess the association between RC and DM. Mediation analysis was used to clarified the mediating role of iron status in the association between the RC and DM.
Results: The average age of the participants was 50.6 (standard deviation = 15.1) years. Higher RC was significantly associated with increased SF (β = 73.14, SE = 3.75, 95% confidence interval [CI] 65.79-80.49) and TBI (β = 1.61, SE = 0.08, 95% CI 1.44-1.78). J-shape relationships were found in the association between RC levels with DM, as well as iron status with DM. Significant indirect effects of SF and TBI in the association between RC and DM were found, with the index mediated at 9.58% and 6.37%, respectively.
Conclusions: RC has a dose-response relationship with iron status. The association between RC and DM was mediated in part by iron status. Future studies are needed to confirm these findings and further clarify the underlying mechanism.
Keywords: Diabetes mellitus; Iron; Mediation; Remnant cholesterol.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus.Cardiovasc Diabetol. 2022 Jun 27;21(1):117. doi: 10.1186/s12933-022-01554-0. Cardiovasc Diabetol. 2022. PMID: 35761281 Free PMC article.
-
Role of remnant cholesterol in the relationship between physical activity and diabetes mellitus: an intermediary analysis.Front Public Health. 2024 Mar 12;12:1322244. doi: 10.3389/fpubh.2024.1322244. eCollection 2024. Front Public Health. 2024. PMID: 38532980 Free PMC article.
-
Remnant cholesterol for the detection of glucose metabolic states in patients with coronary heart disease angina pectoris.Acta Diabetol. 2022 Oct;59(10):1339-1347. doi: 10.1007/s00592-022-01935-7. Epub 2022 Jul 23. Acta Diabetol. 2022. PMID: 35871108
-
The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes.Cardiovasc Diabetol. 2020 Jul 6;19(1):104. doi: 10.1186/s12933-020-01076-7. Cardiovasc Diabetol. 2020. PMID: 32631321 Free PMC article.
-
Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment.Front Cardiovasc Med. 2022 Oct 17;9:913869. doi: 10.3389/fcvm.2022.913869. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36324753 Free PMC article. Review.
Cited by
-
Association of non-traditional lipid indices with diabetes and insulin resistance in US adults: mediating effects of HOMA-IR and evidence from a national cohort.Clin Exp Med. 2025 Aug 7;25(1):281. doi: 10.1007/s10238-025-01819-4. Clin Exp Med. 2025. PMID: 40773099 Free PMC article.
References
-
- ID Federation . IDF Diabetes Atlas, 10th edn. IDF Diabetes Atlas. 10. Brussels: International Diabetes Federation; 2021.
Grants and funding
LinkOut - more resources
Full Text Sources